Theramx Inc. products

Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a wearable EEG (AI-electroencephalogram) measuring instrument allowing.

Biosensing technology that enables early diagnosis and prevention of diseases through an analysis of complex causal substances (proteins, lipids, organic acids, etc.) for dementia or metabolic syndrome, etc., as well as analysis/detection of composite biomarkers utilizing AI technology.